SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-16-159788
Filing Date
2016-11-30
Accepted
2016-11-30 16:31:05
Documents
5
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a16-22338_110ka.htm 10-K/A 138701
2 EX-10.23 a16-22338_1ex10d23.htm EX-10.23 319393
3 EX-10.24 a16-22338_1ex10d24.htm EX-10.24 367197
4 EX-31.3 a16-22338_1ex31d3.htm EX-31.3 10981
5 EX-31.4 a16-22338_1ex31d4.htm EX-31.4 11006
  Complete submission text file 0001104659-16-159788.txt   848391
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36306 | Film No.: 162025570
SIC: 2834 Pharmaceutical Preparations